RLAY (STOCKS)
Relay Therapeutics, Inc. Common Stock
$15.030000
+0.220000 (+1.49%)
Prev close: $14.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sanjiv K. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,265.84M
- Employees
- 197
- P/E (TTM)
- -9.56
- P/B (TTM)
- 4.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $10.68M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $307.14M |
| Operating Expenses | $307.14M |
| Operating Income/Loss | -$296.46M |
| Income/Loss From Continuing Operations After Tax | -$272.71M |
| Income/Loss From Continuing Operations Before Tax | -$134.52M |
| Net Income/Loss | -$272.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$272.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$272.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.56 |
| Diluted Earnings Per Share | -$1.56 |
| Basic Average Shares | 524,115,637 |
| Assets | $699.61M |
| Current Assets | $658.46M |
| Prepaid Expenses | $11.84M |
| Other Current Assets | $646.63M |
| Noncurrent Assets | $41.15M |
| Fixed Assets | $1.22M |
| Other Non-current Assets | $39.93M |
| Liabilities | $57.43M |
| Current Liabilities | $29.75M |
| Accounts Payable | $4.10M |
| Other Current Liabilities | $25.65M |
| Noncurrent Liabilities | $27.68M |
| Equity | $642.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $642.18M |
| Liabilities And Equity | $699.61M |
| Net Cash Flow From Operating Activities | -$213.36M |
| Net Cash Flow From Operating Activities, Continuing | -$213.36M |
| Net Cash Flow From Investing Activities | $183.24M |
| Net Cash Flow From Investing Activities, Continuing | $183.24M |
| Net Cash Flow From Financing Activities | $109.64M |
| Net Cash Flow From Financing Activities, Continuing | $109.64M |
| Net Cash Flow | $79.52M |
| Net Cash Flow, Continuing | $79.52M |
| Comprehensive Income/Loss | -$271.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$272.18M |
| Other Comprehensive Income/Loss | $523.00K |